The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 04, 2017

Filed:

Nov. 06, 2013
Applicant:

University of Pittsburgh—of the Commonwealth System of Higher Education, Pittsburgh, PA (US);

Inventors:

Thomas E. Smithgall, Wexford, PA (US);

Lori Ann Emert-Sedlak, Cranberry Township, PA (US);

Billy W. Day, Upper St. Clair, PA (US);

Jielu Zhao, Pittsburgh, PA (US);

Prema Chandrasekhar Iyer, Pittsburgh, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 231/46 (2006.01); C07D 405/04 (2006.01); C07D 401/12 (2006.01); A61K 39/39 (2006.01); A61K 31/5377 (2006.01); A61K 31/655 (2006.01); A61K 31/415 (2006.01); A61K 45/06 (2006.01); A61K 31/4155 (2006.01); A61K 31/4178 (2006.01); A61K 31/427 (2006.01); A61K 31/429 (2006.01); A61K 31/4439 (2006.01); C07D 231/20 (2006.01); C07D 403/04 (2006.01); C07D 401/04 (2006.01); C07D 417/04 (2006.01);
U.S. Cl.
CPC ...
C07D 231/46 (2013.01); A61K 31/415 (2013.01); A61K 31/4155 (2013.01); A61K 31/4178 (2013.01); A61K 31/427 (2013.01); A61K 31/429 (2013.01); A61K 31/4439 (2013.01); A61K 31/5377 (2013.01); A61K 31/655 (2013.01); A61K 39/39 (2013.01); A61K 45/06 (2013.01); C07D 231/20 (2013.01); C07D 401/04 (2013.01); C07D 401/12 (2013.01); C07D 403/04 (2013.01); C07D 405/04 (2013.01); C07D 417/04 (2013.01);
Abstract

Disclosed herein are embodiments of a compound capable of treating HIV. In particular disclosed embodiments, the compound is capable of inhibiting Nef, such as by acting as antagonists of HIV Nef function. Also disclosed are embodiments of a method of making the compound, embodiments of a method of using the compound, and embodiments of a method of identifying HIV Nef antagonists. The disclosed compound may be used alone or in combination with other pharmacologically active agents in order to promote reducing drug resistance and/or cumulative toxicity.


Find Patent Forward Citations

Loading…